Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Differential regulation of the unfolded protein response in outbred deer mice and susceptibility to metabolic disease.

Havighorst A, Zhang Y, Farmaki E, Kaza V, Chatzistamou I, Kiaris H.

Dis Model Mech. 2019 Feb 7. pii: dmm.037242. doi: 10.1242/dmm.037242. [Epub ahead of print]

2.

The Value of Outbred Rodent Models in Cancer Research.

Chatzistamou I, Farmaki E, Kaza V, Kiaris H.

Trends Cancer. 2018 Jul;4(7):468-471. doi: 10.1016/j.trecan.2018.05.004. Epub 2018 Jun 7.

PMID:
29937045
3.

Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Nalbanti P, Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Farmaki E, Bamidis P, Papachristou F.

Rheumatol Int. 2018 Jul;38(7):1241-1250. doi: 10.1007/s00296-018-4062-9. Epub 2018 May 29.

PMID:
29845429
4.

Growth of human breast cancers in Peromyscus.

Kaza V, Farmaki E, Havighorst A, Crossland J, Chatzistamou I, Kiaris H.

Dis Model Mech. 2018 Jan 17;11(1). pii: dmm031302. doi: 10.1242/dmm.031302.

5.

SIAE Rare Variants in Juvenile Idiopathic Arthritis and Primary Antibody Deficiencies.

Sevdali E, Tsitsami E, Tsinti M, Farmaki E, Papadopoulou-Alataki E, Germenis AE, Speletas M.

J Immunol Res. 2017;2017:1514294. doi: 10.1155/2017/1514294. Epub 2017 Aug 16.

6.

Matrix metalloproteinases in ureteropelvic junction obstruction.

Pavlaki A, Printza N, Farmaki E, Stabouli S, Taparkou A, Dotis J, Papachristou F.

Hippokratia. 2017 Jul-Sep;21(3):136-139.

7.

Natural History, Pathogenesis, and Treatment of Evans Syndrome in Children.

Mantadakis E, Farmaki E.

J Pediatr Hematol Oncol. 2017 Aug;39(6):413-419. doi: 10.1097/MPH.0000000000000897. Review.

PMID:
28654461
8.

Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3.

Farmaki E, Kaza V, Papavassiliou AG, Chatzistamou I, Kiaris H.

Cancer Lett. 2017 Mar 28;389:49-58. doi: 10.1016/j.canlet.2016.12.028. Epub 2016 Dec 29.

9.

Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

Koutsonikoli A, Trachana M, Farmaki E, Tzimouli V, Pratsidou-Gertsi P, Printza N, Garyphallos A, Galanopoulou V, Kanakoudi-Tsakalidou F, Papachristou F.

Clin Exp Immunol. 2017 Apr;188(1):79-85. doi: 10.1111/cei.12913. Epub 2017 Jan 22.

10.

Assessment of IgE-mediated food allergies in children with atopic dermatitis.

Mavroudi A, Karagiannidou A, Xinias I, Cassimos D, Karantaglis N, Farmaki E, Imvrios G, Fotoulaki M, Eboriadou M, Tsanakas J.

Allergol Immunopathol (Madr). 2017 Jan - Feb;45(1):77-81. doi: 10.1016/j.aller.2016.06.006. Epub 2016 Oct 4.

PMID:
27717723
11.

Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

de la Morena MT, Leonard D, Torgerson TR, Cabral-Marques O, Slatter M, Aghamohammadi A, Chandra S, Murguia-Favela L, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina A, Hanson IC, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JD, Chou J, Abbott JK, van Montfrans J, González-Granado LI, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Cunningham-Rundles C, Knutsen AP, Sleasman J, Costa Carvalho BT, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich A, Cowan M, Gennery A, Cant A, Notarangelo LD, Roifman CM.

J Allergy Clin Immunol. 2017 Apr;139(4):1282-1292. doi: 10.1016/j.jaci.2016.07.039. Epub 2016 Sep 30.

12.

Brittle Hair, Photosensitivity, Brain Hypomyelination and Immunodeficiency: Clues to Trichothiodystrophy.

Farmaki E, Nedelkopoulou N, Delli F, Sarafidis K, Zafeiriou DI.

Indian J Pediatr. 2017 Jan;84(1):89-90. doi: 10.1007/s12098-016-2209-9. Epub 2016 Jul 30. No abstract available.

PMID:
27473476
13.

A CCL8 gradient drives breast cancer cell dissemination.

Farmaki E, Chatzistamou I, Kaza V, Kiaris H.

Oncogene. 2016 Dec 8;35(49):6309-6318. doi: 10.1038/onc.2016.161. Epub 2016 May 16.

14.

Endoplasmic reticulum stress is associated with the pathogenesis of pemphigus vulgaris.

Mihailidou C, Katsoulas N, Panagiotou E, Farmaki E, Sklavounou A, Kiaris H, Chatzistamou I.

Exp Dermatol. 2016 Sep;25(9):731-3. doi: 10.1111/exd.13026. Epub 2016 Jun 15. No abstract available.

PMID:
27060358
15.

Validation study of the pediatric allergic rhinitis quality of life questionnaire.

Mavroudi A, Chrysochoou EA, Boyle RJ, Papastergiopulos A, Karantaglis N, Karagiannidou A, Xinias I, Farmaki E, Hatziagorou E, Kirvassilis F, Kourentas G, Tsanakas J, Warner JO.

Asian Pac J Allergy Immunol. 2016 Jun;34(2):159-65. doi: 10.12932/AP0651.34.2.2016.

16.

Serum levels of ghrelin and obestatin in children with symptoms suggestive of delayed gastric emptying of unclear etiology.

Saliakellis E, Karatzas N, Iakovou I, Farmaki E, Varlamis G, Fotoulaki M.

Ann Gastroenterol. 2015 Oct-Dec;28(4):452-6.

17.

Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.

Psarros F, Koutsostathis N, Farmaki E, Speletas MG, Germenis AE.

Int Arch Allergy Immunol. 2014;164(4):326-32. doi: 10.1159/000366276. Epub 2014 Sep 23.

PMID:
25277223
18.

Host genetics and opportunistic fungal infections.

Pana ZD, Farmaki E, Roilides E.

Clin Microbiol Infect. 2014 Dec;20(12):1254-64. doi: 10.1111/1469-0691.12800. Epub 2014 Dec 19. Review.

19.

Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.

Gargalionis AN, Korkolopoulou P, Farmaki E, Piperi C, Dalagiorgou G, Adamopoulos C, Levidou G, Saetta A, Fragkou P, Tsioli P, Kiaris H, Zizi-Serbetzoglou A, Karavokyros I, Papavassiliou KA, Tsavaris N, Patsouris E, Basdra EK, Papavassiliou AG.

Int J Cancer. 2015 Apr 1;136(7):1515-27. doi: 10.1002/ijc.29140. Epub 2014 Sep 3.

20.

Endoplasmic Reticulum Stress-Associated Chaperones, Bip/GRP78 and Calnexin are Overexpressed in Keratocystic Odontogenic Tumours.

Pavli M, Farmaki E, Merkourea S, Vastardis H, Sklavounou A, Tzerbos F, Chatzistamou I.

J Oral Maxillofac Res. 2014 Apr 1;5(1):e3. doi: 10.5037/jomr.2014.5103. eCollection 2014 Jan.

21.

Environmental impact of intensive aquaculture: investigation on the accumulation of metals and nutrients in marine sediments of Greece.

Farmaki EG, Thomaidis NS, Pasias IN, Baulard C, Papaharisis L, Efstathiou CE.

Sci Total Environ. 2014 Jul 1;485-486:554-562. doi: 10.1016/j.scitotenv.2014.03.125. Epub 2014 Apr 17.

PMID:
24747247
22.

Clinical picture and treatment of 2212 patients with common variable immunodeficiency.

Gathmann B, Mahlaoui N; CEREDIH, Gérard L, Oksenhendler E, Warnatz K, Schulze I, Kindle G, Kuijpers TW; Dutch WID, van Beem RT, Guzman D, Workman S, Soler-Palacín P, De Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H, Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U, Meyts I, Kutukculer N, Wågström P, Galal NM, Roesler J, Farmaki E, Zinovieva N, Ciznar P, Papadopoulou-Alataki E, Bienemann K, Velbri S, Panahloo Z, Grimbacher B; European Society for Immunodeficiencies Registry Working Party.

J Allergy Clin Immunol. 2014 Jul;134(1):116-26. doi: 10.1016/j.jaci.2013.12.1077. Epub 2014 Feb 28.

PMID:
24582312
23.

Mannose binding lectin and ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia.

Pana ZD, Samarah F, Papi R, Antachopoulos C, Papageorgiou T, Farmaki E, Hatzipantelis E, Tragiannidis A, Vavatsi-Christaki N, Kyriakidis D, Athanassiadou-Piperopoulou F, Roilides E.

Pediatr Blood Cancer. 2014 Jun;61(6):1017-22. doi: 10.1002/pbc.24951. Epub 2014 Jan 22.

PMID:
24453114
24.

Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?

Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V, Taparkou A, Paterakis G, Trachana M, Pratsidou-Gertsi P, Nalbanti P, Papachristou F.

Lupus. 2014 Mar;23(3):305-12. doi: 10.1177/0961203313519157. Epub 2014 Jan 7.

PMID:
24399813
25.

Selection of p53-Deficient Stromal Cells in the Tumor Microenvironment.

Farmaki E, Chatzistamou I, Bourlis P, Santoukou E, Trimis G, Papavassiliou AG, Kiaris H.

Genes Cancer. 2012 Sep;3(9-10):592-8. doi: 10.1177/1947601912474002.

26.

Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells.

Adamopoulos C, Farmaki E, Spilioti E, Kiaris H, Piperi C, Papavassiliou AG.

Clin Chem Lab Med. 2014 Jan 1;52(1):151-60. doi: 10.1515/cclm-2012-0826.

PMID:
23454718
27.

p53 antagonizes the unfolded protein response and inhibits ground glass hepatocyte development during endoplasmic reticulum stress.

Dioufa N, Chatzistamou I, Farmaki E, Papavassiliou AG, Kiaris H.

Exp Biol Med (Maywood). 2012 Oct;237(10):1173-80. doi: 10.1258/ebm.2012.012140. Epub 2012 Oct 4.

PMID:
23038705
28.

Comparison of multiple linear regression, partial least squares and artificial neural networks for prediction of gas chromatographic relative retention times of trimethylsilylated anabolic androgenic steroids.

Fragkaki AG, Farmaki E, Thomaidis N, Tsantili-Kakoulidou A, Angelis YS, Koupparis M, Georgakopoulos C.

J Chromatogr A. 2012 Sep 21;1256:232-9. doi: 10.1016/j.chroma.2012.07.064. Epub 2012 Jul 28.

PMID:
22901297
29.

Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities.

Porter DC, Farmaki E, Altilia S, Schools GP, West DK, Chen M, Chang BD, Puzyrev AT, Lim CU, Rokow-Kittell R, Friedhoff LT, Papavassiliou AG, Kalurupalle S, Hurteau G, Shi J, Baran PS, Gyorffy B, Wentland MP, Broude EV, Kiaris H, Roninson IB.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13799-804. doi: 10.1073/pnas.1206906109. Epub 2012 Aug 6.

30.

Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.

Dioufa N, Farmaki E, Schally AV, Kiaris H, Vlahodimitropoulos D, Papavassiliou AG, Kittas C, Block NL, Chatzistamou I.

Horm Cancer. 2012 Aug;3(4):172-80. doi: 10.1007/s12672-012-0108-8. Epub 2012 Mar 23.

PMID:
22441816
31.

Acute phase 99mTc-dimercaptosuccinic acid scan in infants with first episode of febrile urinary tract infection.

Printza N, Farmaki E, Piretzi K, Arsos G, Kollios K, Papachristou F.

World J Pediatr. 2012 Feb;8(1):52-6. doi: 10.1007/s12519-012-0335-7. Epub 2012 Jan 27.

PMID:
22282382
32.

A comparative chemometric study for water quality expertise of the Athenian water reservoirs.

Farmaki EG, Thomaidis NS, Simeonov V, Efstathiou CE.

Environ Monit Assess. 2012 Dec;184(12):7635-52. doi: 10.1007/s10661-012-2524-1. Epub 2012 Jan 21.

PMID:
22270597
33.

Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes.

Stasinakis AS, Mermigka S, Samaras VG, Farmaki E, Thomaidis NS.

Environ Sci Pollut Res Int. 2012 Jun;19(5):1574-83. doi: 10.1007/s11356-011-0661-7. Epub 2011 Nov 25.

PMID:
22116734
34.

Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece.

Trachana M, Koutsonikoli A, Farmaki E, Printza N, Tzimouli V, Papachristou F.

Rheumatol Int. 2013 Mar;33(3):809-13. doi: 10.1007/s00296-011-2239-6. Epub 2011 Nov 19.

PMID:
22101555
35.

Outbreak of bloodstream infections because of Serratia marcescens in a pediatric department.

Iosifidis E, Farmaki E, Nedelkopoulou N, Tsivitanidou M, Kaperoni M, Pentsoglou V, Pournaras S, Athanasiou-Metaxa M, Roilides E.

Am J Infect Control. 2012 Feb;40(1):11-5. doi: 10.1016/j.ajic.2011.03.020.

PMID:
21856046
36.

ERp29 regulates response to doxorubicin by a PERK-mediated mechanism.

Farmaki E, Mkrtchian S, Papazian I, Papavassiliou AG, Kiaris H.

Biochim Biophys Acta. 2011 Jun;1813(6):1165-71. doi: 10.1016/j.bbamcr.2011.03.003. Epub 2011 Mar 22.

37.

Frequency, clinical characteristics, and genotype distribution of rotavirus gastroenteritis in Greece (2007-2008).

Koukou D, Grivea I, Roma E, Tsioni H, Trimis G, Galanakis E, Farmaki E, Iosifidis E, Michos A, Siamopoulou-Mavridou A, Kalmanti M, Papadopoulou H, Roilides E, Theodoridou M, Syrogiannopoulos GA, Syriopoulou V; Greek Rotascore Extension Study Group.

J Med Virol. 2011 Jan;83(1):165-9. doi: 10.1002/jmv.21945.

PMID:
21108355
38.

Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions.

Printza N, Farmaki E, Bosdou J, Gkogka C, Papachristou F.

Hum Vaccin. 2010 Oct;6(10):819-22. Epub 2010 Oct 1.

PMID:
20930563
39.

Hydrolysis of 2-arachidonoylglycerol in Tetrahymena thermophila. Identification and partial characterization of a Monoacylglycerol Lipase-like enzyme.

Evagorou A, Anagnostopoulos D, Farmaki E, Siafaka-Kapadai A.

Eur J Protistol. 2010 Nov;46(4):289-97. doi: 10.1016/j.ejop.2010.06.001.

PMID:
20889319
40.

Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia.

Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, Farmaki E, Tzimouli V, Tsatra I, Gompakis N, Athanassiou-Metaxa M.

Haemophilia. 2011 Jan;17(1):e217-22. doi: 10.1111/j.1365-2516.2010.02385.x. Epub 2010 Sep 2.

PMID:
20825502
41.

Haematuria in a young patient with severe haemophilia and inhibitor presence receiving prophylactic treatment with recombinant factor VIIa.

Economou M, Papadopoulou E, Vagianou I, Farmaki E, Gompakis N, Athanassiou-Metaxa M.

Blood Coagul Fibrinolysis. 2010 Sep;21(6):611-3. doi: 10.1097/MBC.0b013e32833c2b79. No abstract available.

PMID:
20703104
42.

A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence?

Mantadakis E, Farmaki E, Thomaidis S, Tsalkidis A, Chatzimichael A.

J Pediatr Hematol Oncol. 2010 Aug;32(6):e227-9. doi: 10.1097/MPH.0b013e3181e33fe0.

PMID:
20539239
43.

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis.

Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V, Trachana M, Pratsidou-Gertsi P, Tritsoni M, Theodoridou M.

Vaccine. 2010 Jul 12;28(31):5109-13. doi: 10.1016/j.vaccine.2010.03.080. Epub 2010 May 12.

PMID:
20470802
44.

A patient with Lemierre syndrome.

Vargiami EG, Farmaki E, Tasiopoulou D, Zafeiriou DI, Badouraki M, Anastasiou A, Karkos C, Gombakis N, Athanasiou-Metaxa M.

Eur J Pediatr. 2010 Apr;169(4):491-3.

PMID:
20187290
45.

Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.

Mantadakis E, Farmaki E, Buchanan GR.

J Pediatr. 2010 Apr;156(4):623-8. doi: 10.1016/j.jpeds.2009.10.015. Epub 2010 Jan 25. Review.

PMID:
20097358
46.

Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia.

Christoforidis A, Economou M, Farmaki E, Tzimouli V, Gombakis N, Athanassiou-Metaxa M.

Ann Hematol. 2010 Aug;89(8):837-8. doi: 10.1007/s00277-009-0894-4. Epub 2010 Jan 19. No abstract available.

PMID:
20084381
47.

High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome.

Piperi C, Themistocleous MS, Papavassiliou GA, Farmaki E, Levidou G, Korkolopoulou P, Adamopoulos C, Papavassiliou AG.

Mol Med. 2010 Jan-Feb;16(1-2):1-9. doi: 10.2119/molmed.2009.00140. Epub 2009 Oct 12.

48.

DNA methylation signature analysis: how easy is it to perform?

Piperi C, Farmaki E, Vlastos F, Papavassiliou AG, Martinet N.

J Biomol Tech. 2008 Dec;19(5):281-4.

49.

Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.

Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M, Kyriazi T, Sofianou D, Roilides E.

Infect Control Hosp Epidemiol. 2008 Jul;29(7):615-22. doi: 10.1086/589333.

PMID:
18624668
50.

Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis.

Piperi C, Vlastos F, Farmaki E, Martinet N, Papavassiliou AG.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1495-501. doi: 10.1111/j.1582-4934.2008.00309.x. Epub 2008 Mar 19. Review.

Supplemental Content

Loading ...
Support Center